Demonstrate that the HydroThermAblation™ procedure is equally effective compared to the Novasure™ procedure in achieving patent satisfaction at twelve months post-treatment for menorrhagia secondary to DUB.
ID
Bron
Verkorte titel
Aandoening
Dysfunctional uterine bleeding
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
Patients satisfaction:<br>
At each follow up visit/ telephone call patients satisfaction was noted. Patients can express their level satisfaction by using - completely satisfied, satisfied, doubtful satisfied or not satisfied.
It¡¯s also noted if any kind of reintervention is performed, such as the use of oral contraceptives or surgery.
Achtergrond van het onderzoek
Objective:
To compare patient satisfaction amd health-related quality of life (HRQoL) after bipolar radio frequency ablation and ablation with a HYDROTHERMABLATOR (HTA) SYSTEM in women with dysfunctional uterine bleeding.
Design:
Randomized clinical trial.
Setting:
Teaching hospital.
Patient(s):
Women suffering from dysfunctional uterine bleeding.
Intervention(s):
Bipolar radio frequency ablation and ablation with aHYDROTHERMABLATOR (HTA) SYSTEM .
Main outcome measure(s):
Patients will be asked to report treatment satisfaction complete HRQoL questionnaires at baseline, and at 3 months, 6 months, and 12 months after surgery. The questionnaires contain the medical outcomes study Short-Form 36 (SF-36) and a structured clinical history questionnaire.
Doel van het onderzoek
Demonstrate that the HydroThermAblation™ procedure is equally effective compared to the Novasure™ procedure in achieving patent satisfaction at twelve months post-treatment for menorrhagia secondary to DUB.
Onderzoeksopzet
N/A
Onderzoeksproduct en/of interventie
Hydrothermablator (HTA) system versus ablation with novasure.
Publiek
P.O. Box 7777
J. Kleijn
De Run 4600
Veldhoven 5500 MB
The Netherlands
+31 (0)040 8888000
J.Kleijn@mmc.nl
Wetenschappelijk
P.O. Box 7777
J. Kleijn
De Run 4600
Veldhoven 5500 MB
The Netherlands
+31 (0)040 8888000
J.Kleijn@mmc.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
1. Refractory menorrhagia with no definable organic cause (dysfunctional uterine bleeding);
2. Ages over 25 years old;
3. Uterine sound measurement of 6.0 ¨C 12 cm (external os to internal fundus);
4. Failed, contraindicated or intolerance to conservative (medical) therapy;
5. Menstrual Diary: A minimum PBLAC score of > 150 for 1 month;
6. Intracavitary pathology, such as type 2 fibromas and small polyps (¡Ü 2cm), confirmed by hysteroscopy or Saline Infused Sonography (SIS).
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
1. Presence of bacteremia, sepsis, or other active systemic infection;
2. Active or recurrent chronic pelvic inflammatory disease;
3. Patients with documented coagulopathies;
4. Symptomatic endometriosis;
5. Prior uterine surgery (except low segment cesarean section) which interrupts the integrity of the uterine wall e.g., transmural myomectomy or classical cesarean section;
6. Prior endometrial ablations;
7. Patients on medications that could thin the myometrial muscle, such as long-term steroid use;
8. Patients on anticoagulants;
9. Desire to have children or to preserve fertility;
10. Patients currently on hormonal birth control therapy or unwilling to use a non-hormonal birth control post-ablation;
11. Abnormal/Obstructed Cavity as confirmed by hysterscopy, Saline Infused Sonography (SIS) or HSG. Specifically:
11.1 Septate or bicornuate uterus or other congenital malformation of the uterine cavity.
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
| Register | ID |
|---|---|
| NTR-new | NL66 |
| NTR-old | NTR98 |
| Ander register | : N/A |
| ISRCTN | ISRCTN23845359 |